These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38654923)

  • 1. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways [Retraction].
    Drug Des Devel Ther; 2024; 18():1263-1264. PubMed ID: 38654923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cinnamaldehyde Inhibits the Function of Osteosarcoma by Suppressing the Wnt/β-Catenin and PI3K/Akt Signaling Pathways.
    Huang Y; Chen J; Yang S; Tan T; Wang N; Wang Y; Zhang L; Yang C; Huang H; Luo J; Luo X
    Drug Des Devel Ther; 2020; 14():4625-4637. PubMed ID: 33154629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TMF Inhibits miR-29a/Wnt/β-Catenin Signaling Through Upregulating Foxo3a Activity in Osteoarthritis Chondrocytes [Retraction].
    Drug Des Devel Ther; 2023; 17():1063-1064. PubMed ID: 37057061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways.
    Huang H; Lu Q; Yuan X; Zhang P; Ye C; Wei M; Yang C; Zhang L; Huang Y; Luo X; Luo J
    Chem Biol Interact; 2022 Sep; 365():110068. PubMed ID: 35917943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotanshinone I Inhibits the Growth of Osteosarcoma Through the Wnt/β-Catenin Signaling Pathway [Retraction].
    Onco Targets Ther; 2023; 16():275-276. PubMed ID: 37078010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retraction: MicroRNA-182 downregulates Wnt/β-catenin signaling, inhibits proliferation, and promotes apoptosis in human osteosarcoma cells by targeting HOXA9.
    Zhang ZF; Wang YJ; Fan SH; Du SX; Li XD; Wu DM; Lu J; Zheng YL
    Oncotarget; 2022; 13():1003. PubMed ID: 36082358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orcinol Glucoside Facilitates the Shift of MSC Fate to Osteoblast and Prevents Adipogenesis via Wnt/β-Catenin Signaling Pathway [Retraction].
    Drug Des Devel Ther; 2023; 17():959-960. PubMed ID: 37013138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corrigendum to ‟Andrographolide inhibits the growth of human osteosarcoma cells by suppressing Wnt/β-catenin, PI3K/AKT and NF-κB signaling pathways" [Chem. Biol. Interact. 365 (2022) 110068].
    Huang H; Lu Q; Yuan X; Zhang P; Ye C; Wei M; Yang C; Zhang L; Huang Y; Luo X; Luo J
    Chem Biol Interact; 2023 May; 377():110463. PubMed ID: 37028235
    [No Abstract]   [Full Text] [Related]  

  • 9. Phospholipase D1 Inhibition Linked to Upregulation of ICAT Blocks Colorectal Cancer Growth Hyperactivated by Wnt/β-Catenin and PI3K/Akt Signaling.
    Kang DW; Lee BH; Suh YA; Choi YS; Jang SJ; Kim YM; Choi KY; Min DS
    Clin Cancer Res; 2017 Dec; 23(23):7340-7350. PubMed ID: 28939743
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitazoxanide inhibits osteosarcoma cells growth and metastasis by suppressing AKT/mTOR and Wnt/β-catenin signaling pathways.
    Ye C; Wei M; Huang H; Wang Y; Zhang L; Yang C; Huang Y; Luo J
    Biol Chem; 2022 Sep; 403(10):929-943. PubMed ID: 35946850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lycorine inhibits tumor growth of human osteosarcoma cells by blocking Wnt/β-catenin, ERK1/2/MAPK and PI3K/AKT signaling pathway.
    Yuan XH; Zhang P; Yu TT; Huang HK; Zhang LL; Yang CM; Tan T; Yang SD; Luo XJ; Luo JY
    Am J Transl Res; 2020; 12(9):5381-5398. PubMed ID: 33042426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI3K/Akt and Wnt/β-catenin Signaling Cross-regulate NF-κB Signaling in TNF-α-induced Human Lgr5
    Zhao X; Ma B; Zhu H; Bai J; Liu L; Li X; Cai J; Wang B; Wang L; Pang Y; Zhang H; Yang YI; Li N; Chen M
    Anticancer Res; 2022 Jul; 42(7):3325-3340. PubMed ID: 35790295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The PI3K/AKT pathway promotes fracture healing through its crosstalk with Wnt/β-catenin.
    Dong J; Xu X; Zhang Q; Yuan Z; Tan B
    Exp Cell Res; 2020 Sep; 394(1):112137. PubMed ID: 32534061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
    Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
    Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model.
    Yothaisong S; Thanee M; Namwat N; Yongvanit P; Boonmars T; Puapairoj A; Loilome W
    Asian Pac J Cancer Prev; 2014; 15(23):10463-8. PubMed ID: 25556493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
    Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
    J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Apoptosis and Autophagy via sirtuin1- and PI3K/Akt/mTOR-Mediated Pathways by Plumbagin in Human Prostate Cancer Cells [Retraction].
    Drug Des Devel Ther; 2022; 16():2437-2438. PubMed ID: 35937567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crosstalk between PI3K/AKT/mTOR and WNT/β-Catenin signaling in GBM - Could combination therapy checkmate the collusion?
    Daisy Precilla S; Biswas I; Kuduvalli SS; Anitha TS
    Cell Signal; 2022 Jul; 95():110350. PubMed ID: 35525406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are Wnt/β-Catenin and PI3K/AKT/mTORC1 Distinct Pathways in Colorectal Cancer?
    Prossomariti A; Piazzi G; Alquati C; Ricciardiello L
    Cell Mol Gastroenterol Hepatol; 2020; 10(3):491-506. PubMed ID: 32334125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retraction: MiR-543 Inhibits the Migration and Epithelial-To-Mesenchymal Transition of TGF-β-Treated Endometrial Stromal Cells via the MAPK and Wnt/β-Catenin Signaling Pathways.
    Pathology and Oncology Research Editorial Office
    Pathol Oncol Res; 2023; 29():1611110. PubMed ID: 37303850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.